|
0230-0250
|
|
JS-02: Joint SIU-International Continence Society (ICS) Session
Co-Chairs: David Manuel Castro Díaz, Spain / Stavros Charalampous, Cyprus
|
|
To view this session in your own time zone, please click here.
Learning Objectives:
At the end of this session, attendees will be able to:
- Recite important information on LUTS and understand that they have a significant impact on the quality of life (QoL) on elderly population while there is a separate consideration from men due to the anatomical and functional differences in the lower urinary tracts between both genders and consequent differences in pathologies affecting them.
- Explain that rational therapeutics is dependent on a sound understanding of the causes and consequences of variability in responses to medicines. Older people display considerable variability in response to medicines, making the optimization of dosage complex.
Methods to promote active learning:
|
|
0230-0240
|
|
Update on Intrinsic Sphincter Dysfunction in Women
Helen O'Connell, Australia
Learning Objectives
- Compare MUCP and abdominal leak point pressures with respect to intrinsic urethral function
- Define abdominal leak point pressure and its relationship to bladder volume
- Evaluate the relative contributions of urethral hypermobility and intrinsic sphincter deficiency in a patient with SUI
- Formulate a management plan in someone with severe urinary incontinence in which ISD could be a factor
|
|
0240-0250
|
|
ELUTS in the Elderly: Are We Dealing with DOA or DU?
Adrian Wagg, Canada
Learning Objectives
- Understand the physiological changes in the aging bladder which may lead to the observation of reduced bladder emptying
- Understand the relationship between DO and Du and the potential for co-existence and transition from DO to DU
- Understand the clinical implications of the coexistence of DO and DU in older persons
|
|
|
0300-0400
|
|
SYMP-07: Indian Urology Symposium
Chair: Rajeev T P, India
Moderators: Madhu Sudan Agrawal, India / Kim Mammen, India
|
|
To view this session in your own time zone, please click here.
|
|
|
|
0300-0405
|
|
MC-04: Master Class 04 - Establishing Standardized Outcome Reporting in Your Urology Practice
Co-Chairs: Matthew Cooperberg, United States / Ghulam Nabi, United Kingdom
|
|
To view this session in your own time zone, please click here.
Learning Objectives:
At the end of this session, attendees will be able to:
- Describe various components of high-quality urologic care, in terms of both processes and outcomes
- Identify existing and emerging data registries to facilitate reporting of outcomes for urologic care
- Plan for eventual mandated and/or public reporting of quality of care data
- Assess and appraise existing literature in their area of urological conditions care
Methods to promote active learning:
- Lectures
- Discussions including question/answer
- Informal and formal feedback through follow-up email addresses made available to delegates at the end of lectures
|
|
|
|
0400-0420
|
|
JS-03: SIU-Society of Urologic Oncology (SUO)/EAU Section of Oncological Urology (ESOU) Session
Co-Chairs: Christopher Evans, United States / Morgan Roupret, France
|
|
To view this session in your own time zone, please click here.
Learning Objectives:
At the end of this session, attendees will be able to:
- Identify the surgical approach, morbidity and outcomes of radical cystectomy in locally advanced disease
- Understand indications, response rates and toxicities of chemotherapy and immunotherapy in urothelial cancer
- Identify the pros and cons of nephron sparing surgery in stage T2 renal cell carcinoma
- Discuss the management options, risks and benefits of therapeutic approaches (Kidney sparing surgery vs. radical NU) for upper tract urothelial carcinoma
- Understand the relevant germline and somatic mutations in patients with advanced prostate cancer and the therapeutic implications
Methods to promote active learning:
|
|
|
|
0400-0500
|
|
CO-02: Controversies in Urology 02 - Controversies in the Management of Kidney Cancer
Co-Chairs: Surena Matin, United States / Amlesh Seth, India
|
|
To view this session in your own time zone, please click here.
Learning Objectives:
At the end of this session, attendees will be able to:
- Understand metastatic kidney cancer is not a single disease with uniform prognosis and understand the need for individually tailored management strategies.
- Understand the advantages and disadvantages of cytoreductive nephrectomy (CN), along with the indications, timing and integration of CN with systemic therapy.
- Debate the advantages and disadvantages of open vs. robotic partial nephrectomy and know how to select the right approach for the right patient in the right setting.
- Understand the nuances of practically managing localized and metastatic kidney cancer
Methods for promoting active learning:
- Case Presentations and Debate
|
|
|
|
0430-0530
|
|
IS-02: Interactive Session 02 - Management of Penile Cancer including Organ-Sparing Approaches
Co-Chairs: Nicola Nicolai, Italy / Curtis Pettaway, United States
|
|
To view this session in your own time zone, please click here.
Learning Objectives:
At the end of this session, attendees will be able to:
- Understand the importance of pathologic stage, tumor location, and histologic variables in determining treatment options for the primary tumor
- Describe the different approaches to managing the primary penile tumor
- Discuss the importance and options for accurately determining inguinal lymph node status among patients with invasive primary tumors and no palpable inguinal adenopath
- Discuss current Multimodality treatment options among patients presenting with bulky regional adenopathy from penile cancer
Methods to promote active learning:
|
|
0430-0445
|
|
Case Type 1: Primary Tumor Management - Management of Lower Risk Primary-CIS, T1a
Panelists
Pierre Blanchard, France
Steve Nicholson, United Kingdom
Nicola Nicolai, Italy
Curtis Pettaway, United States
Philippe E Spiess, United States
Topics covered: Organ sparing approaches Topical, Laser, Surgery, radiotherapy, sexual function |
|
0445-0510
|
|
Case Type 2: Management of High-Risk Primary and Clinically Negative Nodes
Panelists
Pierre Blanchard, France
Steve Nicholson, United Kingdom
Nicola Nicolai, Italy
Curtis Pettaway, United States
Philippe E Spiess, United States
Topics covered
- Management of high-risk primary tumor, glansectomy, partial penectomy, radical penectomy, radiation
- Inguinal topics -Observation, risk category for dissection, dynamic sentinel node biopsy, Various inguinal node dissection techniques
|
|
0510-0530
|
|
Case Type 3: Management of Bulky Inguinal Lymph Nodes at Presentation
Panelists
Pierre Blanchard, France
Steve Nicholson, United Kingdom
Nicola Nicolai, Italy
Curtis Pettaway, United States
Philippe E Spiess, United States
Topics Covered: Upfront Surgery with Adjuvant Therapy, Neoadjuvant Therapy, Clinical Trials |
|
|
0500-0550
|
|
IC-04: Instructional Course 04 - The Current Situation of Antimicrobial-Resistant Pathogens In Urological Fields
Co-Chairs: Satoshi Takahashi, Japan / Koichiro Wada, Japan
|
|
To view this session in your own time zone, please click here.
Learning Objectives:
At the end of this session, attendees will be able to:
- Recall the current situation of antimicrobial-resistant pathogens and management for UTI caused by antimicrobial-resistant pathogens
Methods to promote active learning:
|
|
|
|
0530-0630
|
|
IC-05: Instructional Course 05 - Metabolic Work Up and Medical Treatment of Stones
Chair: Mohamed El-Shazly, Egypt
|
|
To view this session in your own time zone, please click here.
Learning Objectives:
At the end of this session, attendees will be able to:
- Recall the basics and practical simplified algorithm of metabolic workup and medical treatment.
- Summarize the simplified practical approach without digging into the dilemma of theories and controversies in this tough topic
- Recite the updated medical treatment protocols for different types of stones
Methods to promote active learning:
|
|
0530-0532
|
|
Introduction
|
|
0532-0550
|
|
Metabolic Work Up of Stones
Mohamed El-Shazly, Egypt
|
|
0550-0610
|
|
Medical Treatment of Calcium Stones
Noor Buchholz, United Arab Emirates
Learning Objectives
- Understand mechanisms of calcium stone formation
- Understand risk factors for calcium stone formation
- Understand metabolic work-up for calcium stone formers
- Understand therapeutic and prophylactic approaches to calcium stone formation
|
|
0610-0630
|
|
Medical Treatment of Uric Acid, Cysteine and Infected (Struvite) Stones
Ahmed El-Nahas, Kuwait
- Know the pathophysiology of uric acid, cystine and struvite stone formation.
- Discuss medical treatment (Oral Dissolution Therapy) for uric acid stones.
- Determine metaphylaxis for Cystine and struvite stones.
|
|
|
0600-0700
|
|
IC-06: Instructional Course 06 - Urethral Stricture Surgery
Chair: Sanjay Kulkarni, India
|
|
To view this session in your own time zone, please click here.
Learning Objectives:
At the end of this session, attendees will be able to:
- Determine criteria for reconstruction based on location and etiology of the stricture
- Recall essential techniques for simple and complex anterior urethral reconstruction
- Apply innovations in penile and bulbar urethral stricture management
- Summarize preoperative and intraoperative preparation for posterior urethroplasty cases after pelvic fracture urethral injury
|
|
|
|
0630-0650
|
|
JS-04: Joint SIU-Endourology Session
Co-Chairs: Mahesh R. Desai, India / Jorge Gutierrez, United States
|
|
To view this session in your own time zone, please click here.
Learning Objectives:
At the end of this session, attendees will be able to:
- Learn different endoscopic surgical techniques for endourology procedures
- Understand the advantages and limitations of percutaneous and ureteroscopic surgeries
- Recognize the best surgical candidates for endoscopic surgery, specifically understand the indications and limitations of the techniques based on stone size and burden
- Understand the different products used for percutaneous and ureteroscopic procedures including access, dilation, stone fragmentation and stone removal
- Learn how properly evaluate and treat patient with endourologic surgeries
Methods to promote active learning:
- Update in different topics of Endourology will be discussed in this joint session. Emphasis will be placed on the indications, limitations, advantages, and description of the different surgical techniques. Faculty will share tips on their surgical techniques as well as tricks for a successful outcome with endourology procedures.
|
|
|
|
0730-0830
|
|
IC-07: Instructional Course 07 - The Many Phenotypes of Neurogenic Bladder
Co-Chairs: John Stoffel, United States / Blayne Welk, Canada
|
|
To view this session in your own time zone, please click here.
Learning Objectives:
At the end of this session, attendees will be able to:
- Describe the many causes of neurogenic bladder
- Detail the various clinical presentation of lower urinary tract symptoms and corresponding urodynamic findings of neurogenic bladder
- Connect the causes, clinical presentation and management into phenotypic groups
Methods to promote active learning:
|
|
0730-0740
|
|
Introduction: Welcome and Brief Review of Etiology and Burden of Neurogenic Bladder Dysfunction, Key History/Physical Exam Tips
John Stoffel, United States
|
|
0740-0825
|
|
Real World Management of Neurourology Cases and Interactive Case Discussion
|
|
|
|
A C6 SCI Patient Who Is Struggling with CIC: Ways to Improve CIC Performance/Adherence and Maximize QOL
Humphrey Atiemo, United States
|
|
|
|
An MS Patient Needing Help Managing SP Catheter Complications
Sara Lenherr, United States
|
|
|
|
A Spina Bifida Patient with Incontinence and Hydro: What Surgical Options to Offer: Diversion/Augment/Type of Catheterization Channel
Sean P. Elliott, United States
|
|
0825-0830
|
|
Conclusion
Blayne Welk, Canada
|
|
|
0730-0830
|
|
SYMP-08: The Future of IPP: The Art and Science of Meeting and Exceeding Patient Expectations
Chair: David Ralph, United Kingdom
|
|
To view this session in your own time zone, please click here.
Learning Objectives:
At the end of this session, attendees will be able to:
• Consistently identify the best candidates for IPP
• Provide preoperative patient support and management that will optimize the likelihood that patients will be satisfied with their procedure
• Provide postoperative support that addresses common patient concerns and quickly identifies and manages complications, should they arise
• Keep your clinic running safely in the era of COVID-19
|
|
|
|
0830-0930
|
|
IC-08: Instructional Course 08 - Urologic Endoscopy in Resource Restricted Environments
Chair: Kymora Scotland, United States
|
|
To view this session in your own time zone, please click here.
Learning Objectives:
At the end of this session, attendees will be able to:
- Learn to define optimal use of instruments in challenging environments
- Understand and compare cost saving practices
- Define and recognize risk from cost saving practices
- Learn of innovations aimed at improving cost saving measures
|
|
0830-0835
|
|
Introduction and Outline of Objectives. Discussion of Disposables
Kymora Scotland, United States
|
|
0835-0840
|
|
The Case for Minimally Invasive Surgery
Cyril Kamadjou, Cameroon
|
|
0840-0855
|
|
Endourology: Advice from the Egyptian Experience
Ehab Tawfiek, Egypt
- Learn to define optimal use of instruments in challenging environments
- Understand and compare cost saving practices
- Define and recognize risk from cost saving practices
- Learn of innovations aimed at improving cost saving measures
|
|
0855-0920
|
|
Tips and Tricks In Endourology
Mohammed Lezrek, Morocco
|
|
0920-0930
|
|
The Sri Lankan Magic Box for Endourology Training
Srinath Chandrasekera, Sri Lanka
|
|
|
0830-0930
|
|
IC-09: Instructional Course 09 - E-Health, Digital Health, Telemedicine: Teleurology 101 — Getting Connected
Co-Chairs: Emmanuel Abara, Canada / Michael Borofsky, United States
|
|
To view this session in your own time zone, please click here.
Learning Objectives:
At the end of this session, attendees will be able to:
- Define the terms e-Health, Digital Health, Telemedicine, and list various services that can be provided in Adult and Pediatric Urology.
- Demonstrate knowledge of Delivery Models of e-Health, Teleurology/Telemedicine systems, procedures, EMRs, and some technical arrangements, e.g. Video-conferencing, e-Consult, Health Informatics; and ‘up and coming’ Artificial Intelligence (AI) and Robotics in Health Care.
- Understand the Regulatory and Medico-legal considerations surrounding the provision of e-health, Telemedicine, etc. in various parts of the world
- List various models available for re-imbursement of services as applicable to various jurisdictions; explore opportunities for using digital technology for delivery of urological education and care in the developing world
- Determine one type of Teleurology service to focus on developing/adopting within 5 years from the end of this course, i.e., 2025.
Methods to promote active learning:
- Case-Based Discussions and Didactic Talks
|
|
|
|
0930-0950
|
|
KN-02: Keynote Speaker
|
|
To view this session in your own time zone, please click here.
|
|
|
|
1000-1045
|
|
INN: SIU Innovators Symposium - Prostate Cancer Debate
Chair: Ashish M. Kamat, United States
Co-Chairs: Dean Elterman, Canada / Imogen Patterson, Australia
|
|
To view this session in your own time zone, please click here.
Learning Objectives:
At the end of this session, attendees will be able to:
- Select the correct therapeutic strategy for patients with localized prostate cancer, depending on different patient and tumor characteristics
- List the advantages and disadvantages of prostate biopsy strategies
- Explain the use of PSMA scan in different clinical settings
- List all the advantages and disadvantages of performing lymph node dissection in prostate cancer patients
Methods to promote active learning:
- Live-Streamed Session, Debate Format
|
|
1000-1005
|
|
Introduction
Chair: Ashish M. Kamat, United States
Co-Chairs
Dean Elterman, Canada
Imogen Patterson, Australia
|
|
1005-1025
|
|
1. Case Presentation: Prostate Cancer in the Elderly
Moderator: Siska van Bruwaene, Belgium
|
|
|
|
A. Case Presentation: To Biopsy or not to Biopsy
Moderator: Siska van Bruwaene, Belgium
|
|
|
|
PRO
Brian F Chapin, United States
|
|
|
|
CON
Laurence Klotz, Canada
|
|
|
|
B. Case Presentation: Surgery versus Radiotherapy
Moderator: Siska van Bruwaene, Belgium
|
|
|
|
PRO
Shusuke Akamatsu, Japan
|
|
|
|
CON
Andrés Hernández-Porras, Mexico
|
|
|
|
Discussion
|
|
1025-1045
|
|
2. Case Discussion: PSMA and Lymph Nodes in Prostate Cancer
|
|
|
|
Case Presentation
Moderator: Siska van Bruwaene, Belgium
|
|
|
|
No Lymph Node Dissection. No PSMA
Wouter Everaerts, Belgium
|
|
|
|
Treatment Tailored by PSMA.
Renu Eapen, Australia
|
|
|
|
Perform Lymph Node Dissection
Karim Touijer, United States
|
|
|
|
Discussion
|
|
|
1130-1150
|
|
JS-05: Joint SIU-Society of Urologic Robotic Surgeons (SURS) Session
Chair: Jihad Kaouk, United States
|
|
To view this session in your own time zone, please click here.
Learning Objectives:
At the end of the session, attendees will be able to:
- State what's new in Robotic Surgical treatment of Kidney, Prostate, and bladder Cancer
- Recognize new emerging procedures in robotic surgery
- Recall technical tips and tricks for current robotic procedures
Methods to promote active learning:
|
|
|
|
1300-1400
|
|
MC-05: Master Class 05 - Managing Lower Urinary Tract Dysfunction in Renal Transplantation
Co-Chairs: William Nahas, Brazil / Puneet Sindhwani, United States
|
|
To view this session in your own time zone, please click here.
Learning Objectives:
At the end of this session, attendees will be able to:
- Assess lower urinary tract dysfunction in patients presenting for transplantation with valve bladder and prune belly
- Recognize hostile bladder and manage it for transplantation
- Identify when to treat UTIs, work up needed and management post transplantation
- Describe bladder outlet obstruction in patients with BPH and plan to safely manage them pre and post transplantation, optimizing outcomes and minimizing morbidity
|
|
|
|
1400-1530
|
|
IC-17: Instructional Course 17 - A Multidisciplinary Team Approach to the Treatment of Urothelial Carcinoma in the Age of Anti-PD1 Agents
Chair: Shaheen Alanee, United States
|
|
To view this session in your own time zone, please click here.
Learning Objectives:
At the end of this session, attendees will be able to:
- Recognize the role of the multidisciplinary team (MDT) approach in the patient journey through treatment with immunotherapy for advanced bladder cancer
- Receive an introduction to systemic Immunotherapy in bladder cancer
- Recall the role of the MDT in identifying and managing immune-related side effects associated with anti-PD1 agents
- Explain the Importance of interdisciplinary communication and education in preventing life-threatening complications
Methods to promote active learning:
|
|
|
|
1530-1550
|
|
PL-00: Closing Message
Honorary Chair: Jean de la Rosette, Türkiye
|
|
To view this session in your own time zone, please click here.
|
